Volume 21 - Issue 8 - August, 2009

New Coating Stent Design for Patients with High-Risk Coronary Lesions for Thrombotic Events: (Full title below)

ABSTRACT: Background. Semisynthetic coating of the Camouflage bare-metal stent (BMS) (Eucatech AG, Rheinfelden, Germany) mimics luminal endothelial cell glycocalix, potentially preventing the activation of the coagulation system. Purpose. We sought to determine in a clinical registry the acute and long-term clinical and angiographic outcomes of this BMS design in patients with acute coronary syndromes (ACS) or who were unable to be on long-term clopidogrel therapy. Methods. From March 2007 to December 2008, 150 patients undergoing coronary stent implantation at three centers in Buenos Aires, A



Retrograde Recanalization of Left Main from Saphenous Vein Graft Supported by Percutaneous Impella Recover LP 2.5 Assist Device

From the Catholic University of the Sacred Heart, Rome, Italy.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted March 2, 2009 and accepted March 31, 2009.

Address for correspondence: Francesco Burzotta, MD, PhD, Catholic University of the Sacred Heart, Cardiology Department, Rome, 00168, Italy. E-mail: f.burzotta@rm.unicatt.it

_______________________________________________

J INVASIVE CARDIOL 2009;21:E147-E150

ABSTRACT: Percutaneous coronary interventions (PCI) in



Clinical Utility of 3 French Infrapopliteal Intervention in the Setting of Critical Limb Ischemia

ABSTRACT: Objectives. To evaluate the clinical utility of 3 Fr infrapopliteal intervention in critical limb ischemia (CLI) patients with isolated infrapopliteal artery disease (IPD). Background. There is considerable scope for the miniaturization of infrapopliteal intervention in the clinical field. Methods. In this study, 3 Fr infrapopliteal intervention was performed in a total of 11 consecutive patients and limbs, selected by operator judgment on the basis of the clinical and angiographical conditions of the patients. The 3 Fr sheath was removed immediately after the completion of the proce



Rapid Transcatheter Occlusion of a Coronary Cameral Fistula Using a Three-Lobed Vascular Occlusion Plug

From the Shaare Zedek Medical Center, Jerusalem, Israel.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted March 2, 2009, provisional acceptance given March 13, 2009, and final version accepted April 7, 2009.

Address for correspondence: David Meerkin, MD, Department of Cardiology, Shaare Zedek Medical Center, POB 3235, Jerusalem, 91031 Israel. E-mail: meerkin@SZMC.org.il

_______________________________________________

ABSTRACT: Transcatheter occlusion of coronary cameral fistulae has been we



When is Smaller Better?

Vascular complications during endovascular intervention remain an important cause of the morbidity and mortality associated with the procedure. Risk factors for vascular complications include older age, location of the arteriotomy site and the size of the arterial sheath.1,2 The ability to reduce the size of the access sheath and still allow insertion of vascular devices is therefore an important aspect of endovascular intervention. While numerous endovascular devices have emerged for use for infrapopliteal intervention, balloon angioplasty remains the mainstay of therapy.3 Angioplasty balloon



Subintimal Angioplasty: To Stent or Not to Stent?

From the Department of Cardiology, Marshfield Clinic, Wausau, Wisconsin and Saint Clares Hospital, Weston, Wisconsin.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted April 8, 2009 and accepted May 21, 2009.

Address for correspondence: Aamir Hameed, MD, FACC, Oklahoma Cardiovascular Associates, 4221 S. Western Suite 4000, Oklahoma City, OK 73109. E-mail: aamirhameed@pol.net

_______________________________________________

ABSTRACT: The favored technique of peripheral subintimal angioplasty i



Decline in the Nationwide Trends in In-Hospital Mortality of Patients undergoing Multivessel Percutaneous Coronary Intervention

ABSTRACT: Background. Advances in the safety of percutaneous coronary interventions have been significant in recent years. The goal of this study was to evaluate any decline in the age-adjusted in-hospital mortality rate in patients undergoing multivessel percutaneous coronary intervention (MVPCI) using a very large database from 1988 to 2004 in the United States. Method. The Nationwide Inpatient Sample (NIS) database was utilized to calculate the age-adjusted mortality rate for MVPCI from 1988 to 2004 in patients over the age of 40 years retrospectively. Specific ICD-9-CM codes for MVPCI wer



Drug-Specific Thienopyridine Resistance in Patient with Recurrent Coronary Stent Thrombosis

From the Department for Cardiovascular Diseases, Zagreb University Hospital Centre, Zagreb, Croatia.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted January 5, 2009, provisional acceptance given May 19, 2009, final version accepted May 28, 2009.

Address for correspondence: Daniel Lovric, MD, Department for Cardiovascular Diseases, Zagreb University Hospital Centre, Kispaticeva 12, Zagreb; 10000, Croatia. E-mail: daniel.lovric@mac.com

_______________________________________________

ABSTRAC



  • « Previous
  •  | Page 1 of 3 | 
  • Next »